CanGaroo

The objective of this study is to explore the subject clinical profiles, procedural details and post-implant outcomes of patients who receive either the CanGaroo ECM Envelope or no envelope at the time of initial implantation.
Contact phone
517..36.4.5760
Principal investigator
Dr. John Ip, M.D., FACC
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation
Webform